AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇳🇬
Topiramate in Nigeria
6 products registered with NAFDAC — 4 active, 2 expired
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| Topamax 50 mg Tablets** Tablet | B4-8212 | J & J Company West Africa Limited | active | 5 Jul 2028 |
| Topamax 25 mg Tablet** Tablet | B4-8211 | J & J Company West Africa Limited | active | 27 Mar 2028 |
| Epimate 100 Tablets Tablet | B4-2509 | Chanrai HealthCare Limited | active | 27 Oct 2026 |
| Epimate 25 Tablets Tablet | B4-2510 | Chanrai HealthCare Limited | active | 27 Oct 2026 |
| HILTOP TABLETS 3X10'S | B4-6824 | NURUSHAT PHARM LTD. 13 | expired | 7 Feb 2022 |
| HILTOP TABLETS 3X10'S | B4-6823 | NURUSHAT PHARM LTD. 13 | expired | 7 Feb 2022 |
Topiramate — NAFDAC Registration Details
NAFDAC (Nigeria) has 6 registered products containing Topiramate, of which 4 are currently active. Data is sourced directly from the official NAFDAC drug register and refreshed daily.
Track Topiramate registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.